Management principles for acute illness in patients with medium-chain acyl-coenzyme a dehydrogenase deficiency

9Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) is a fatty acid oxidation disorder in which the patient is unable to break down fats to produce energy. This disorder places children at risk for metabolic decompensation during periods of stress, such as routine childhood illnesses. The intent of this clinical report is to provide pediatricians with additional information regarding the acute clinical care of patients with MCADD. Although each patient with MCADD will still be expected to have a primary metabolic physician, the involvement of the primary care provider is crucial as well. Appropriate treatment of children with MCADD can lead to avoidance of morbidity and mortality.

Cite

CITATION STYLE

APA

McGregor, T. L., Berry, S. A., Dipple, K. M., & Hamid, R. (2021). Management principles for acute illness in patients with medium-chain acyl-coenzyme a dehydrogenase deficiency. Pediatrics, 147(1). https://doi.org/10.1542/PEDS.2020-040303

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free